Kura oncology, inc. (KURA)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Operating Expenses:
Research and development (includes related party amounts of $132 and $53 for the three months ended March 31, 2020 and 2019, respectively)

50,019

47,826

47,072

46,145

45,902

46,787

43,086

38,414

32,473

26,426

21,930

19,427

18,228

16,575

16,145

15,482

14,868

13,905

11,619

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Research and development, related party

-

-

448

496

-

-

1,048

1,201

1,318

-

1,880

2,557

3,040

3,829

3,869

3,851

3,930

3,872

3,697

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative

-

-

18,362

17,566

-

-

14,152

12,214

10,695

-

8,546

7,950

7,571

7,861

7,631

7,693

7,347

6,019

5,570

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative, related party

-

-

342

325

-

-

270

244

241

-

204

185

141

102

86

75

72

69

71

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Formation costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

General and administrative (includes related party amounts of $111 and $87 for the three months ended March 31, 2020 and 2019, respectively)

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

23

22

21

22

22

23

23

22

22

21

22

23

23

19

19

0

0

0

Total operating expenses

72,728

67,479

65,150

63,458

62,843

62,883

57,244

50,761

43,415

36,077

32,560

30,119

28,980

28,367

27,731

27,101

26,217

23,865

20,957

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other Income (Expense):
Management fee income, related party

134

245

411

560

666

735

750

765

780

780

780

780

780

885

990

1,095

1,200

1,200

1,200

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest income

4,763

4,674

4,496

4,147

3,749

3,169

2,423

1,573

1,073

751

579

513

513

499

407

298

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-23

-22

-21

-22

-22

-23

-23

-22

-22

-21

-22

-23

-23

-19

-19

0

0

0

Interest expense

579

580

631

738

857

970

1,027

1,001

943

888

832

795

0

-

0

0

-

42

79

80

82

41

6

6

6

5

5

5

5

4

4

4

3

3

3

2

0

0

0

Interest expense, related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

46

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other income

4,318

4,339

3,778

3,471

3,060

2,436

2,146

1,337

910

643

527

493

513

807

1,044

1,250

1,442

1,240

1,135

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Loss

-68,410

-63,140

-61,372

-59,987

-59,783

-60,447

-55,098

-49,424

-42,505

-35,434

-32,033

-29,626

-28,467

-27,560

-26,687

-25,851

-24,775

-22,625

-19,822

-13,738

-8,160

-3,690

-28

-28

-28

-28

-28

-28

-27

-27

-26

-26

-27

-27

-22

-22

0

0

0

Net loss per share, basic and diluted

-0.42

-0.40

-0.36

-0.38

-0.37

-0.41

-0.40

-0.45

-0.46

-0.35

-0.38

-0.40

-0.39

-0.38

-0.37

-0.36

-0.36

0.24

-0.57

-0.54

-1.41

-25.98

0.00

0.00

0.00

-0.01

0.00

0.00

0.00

-0.01

0.00

0.00

0.00

-0.01

0.00

0.00

0.00

0.00

0.00

Weighted average number of shares used in computing net loss per share, basic and diluted

45,411

45,447

45,241

38,928

38,168

38,175

37,789

32,971

31,829

29,351

24,344

19,789

19,464

19,161

18,850

18,548

18,245

15,405

10,723

10,420

3,184

141

5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

5,000

-

5,000

5,000

-

-

-

Comprehensive Loss:
Net loss

-68,410

-63,140

-61,372

-59,987

-59,783

-60,447

-55,098

-49,424

-42,505

-35,434

-32,033

-29,626

-28,467

-27,560

-26,687

-25,851

-24,775

-22,625

-19,822

-13,738

-8,160

-3,690

-28

-28

-28

-28

-28

-28

-27

-27

-26

-26

-27

-27

-22

-22

0

0

0

Other comprehensive income:
Unrealized gain (loss) on marketable securities and foreign currency

543

462

455

254

86

-82

-109

-71

-49

-31

-25

-67

-30

69

113

133

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive Loss

-67,867

-62,678

-60,917

-59,733

-59,697

-60,529

-55,207

-49,495

-42,554

-35,465

-32,058

-29,693

-28,497

-27,491

-26,677

-25,792

-24,764

-22,712

-19,821

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted-average number of common shares outstanding (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,000

5,000

5,000